This page has only limited features, please log in for full access.

Dr. Henning Sommermeyer
Department of Medicine, The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz, Nowy Šwiat 4, 62-800 Kalisz, Poland

Basic Info


Research Keywords & Expertise

0 Probiotics
0 antibiotics
0 Klebsiella pneumoniae
0 prebiotics
0 microbiota

Honors and Awards

The user has no records in this section


Career Timeline

The user has no records in this section.


Short Biography

The user biography is not available.
Following
Followers
Co Authors
The list of users this user is following is empty.
Following: 0 users

Feed

Journal article
Published: 30 May 2021 in International Journal of Environmental Research and Public Health
Reads 0
Downloads 0

Diarrhea is a common problem in nursing homes. A survey among nursing facilities in Poland was used to characterize diarrhea outbreaks, the burden caused for residents and caregivers and the employed measures. Survey results confirmed that diarrhea is a common problem in nursing homes and in most cases affects groups of residents. The related burden is high or very high for 27% of residents and 40% of caregivers. In 80% of nursing facilities pro or synbiotics are part of the measures used to manage diarrhea. Administration of these kinds of products has been suggested for the management of diarrhea, especially in cases caused by Clostridioides (C.) difficile. C. difficile is one of many potential causes for diarrhea, but is of particular concern for nursing homes because it is responsible for a large proportion of diarrhea outbreaks and is often caused by multi-drug resistant strains. In vitro inhibition of a quinolone-resistant and a multi-drug resistant C. difficile strain was used to evaluate the growth inhibitory effects of commonly used products containing probiotic microorganisms. Growth of both strains was best inhibited by multi-strain synbiotic preparations. These findings suggest that multi-strain synbiotics can be considered as an interventional option for diarrhea caused by C. difficile.

ACS Style

Henning Sommermeyer; Hanna Pituch; Dorota Wultanska; Paulina Wojtyla-Buciora; Jacek Piatek; Malgorzata Bernatek. Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics—An Option for Diarrhea Management in Nursing Facilities. International Journal of Environmental Research and Public Health 2021, 18, 5871 .

AMA Style

Henning Sommermeyer, Hanna Pituch, Dorota Wultanska, Paulina Wojtyla-Buciora, Jacek Piatek, Malgorzata Bernatek. Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics—An Option for Diarrhea Management in Nursing Facilities. International Journal of Environmental Research and Public Health. 2021; 18 (11):5871.

Chicago/Turabian Style

Henning Sommermeyer; Hanna Pituch; Dorota Wultanska; Paulina Wojtyla-Buciora; Jacek Piatek; Malgorzata Bernatek. 2021. "Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics—An Option for Diarrhea Management in Nursing Facilities." International Journal of Environmental Research and Public Health 18, no. 11: 5871.

Journal article
Published: 25 September 2020 in International Journal of Environmental Research and Public Health
Reads 0
Downloads 0

The objective of the study was to characterize how infantile colic is perceived and managed by German and Polish pediatricians. Data in both countries were collected by using a paper questionnaire with seven questions and predefined and free text fields for the answers. Answers from 160 German and 133 Polish pediatricians were collected. The average of the occurrence rates estimated by both responder groups were at the higher end of published rates. The majority of pediatricians from both countries rated the parental burden caused by infantile colic to be high or very high. Pediatricians’ awareness about the association between infantile colic and maternal depression and premature termination of breastfeeding is relatively well established in both countries. While more than 90% of German pediatricians stated knowledge of infantile colic being a major risk factor for shaken baby syndrome, this knowledge was only declared by half of the Polish responders. Pharmacological interventions, pro-/synbiotics or simethicone, are part of the treatment repertoire of nearly all responding pediatricians. In addition, non-pharmacological interventions (e.g., change of feeding, change of parental behavior) are also among the employed interventions. Results of this study will allow to better design and prioritize communication about infantile colic directed at pediatricians.

ACS Style

Henning Sommermeyer; Hanna Krauss; Zuzanna Chęcińska-Maciejewska; Marcin Pszczola; Jacek Piątek. Infantile Colic—The Perspective of German and Polish Pediatricians in 2020. International Journal of Environmental Research and Public Health 2020, 17, 7011 .

AMA Style

Henning Sommermeyer, Hanna Krauss, Zuzanna Chęcińska-Maciejewska, Marcin Pszczola, Jacek Piątek. Infantile Colic—The Perspective of German and Polish Pediatricians in 2020. International Journal of Environmental Research and Public Health. 2020; 17 (19):7011.

Chicago/Turabian Style

Henning Sommermeyer; Hanna Krauss; Zuzanna Chęcińska-Maciejewska; Marcin Pszczola; Jacek Piątek. 2020. "Infantile Colic—The Perspective of German and Polish Pediatricians in 2020." International Journal of Environmental Research and Public Health 17, no. 19: 7011.

Journal article
Published: 11 May 2020 in International Journal of Environmental Research and Public Health
Reads 0
Downloads 0

A variety of activities potentially contribute to the beneficial effects of probiotic bacteria observed in humans. Among these is a direct inhibition of the growth of pathogenic bacteria in the gut. The present study characterizes head-to-head the in-vitro pathogen growth inhibition of clinically relevant infectious bacterial strains by different types of probiotics and a synbiotic. In-vitro growth inhibition of Escherichia (E.) coli EPEC, Shigella (Sh.) sonnei, Salmonella (S.) typhimurium, Klebsiella (K.) pneumoniae and Clostridioides (C.) difficile were determined. Investigated products were a yeast mono strain probiotic containing Saccharomyces (Sac.) boulardii, bacterial mono strain probiotics containing either Lactobacillus (L.) rhamnosus GG or L. reuteri DSM 17938, a multi strain probiotic containing three L. rhamnosus strains (E/N, Oxy, Pen), and a multi strain synbiotic containing nine different probiotic bacterial strains and the prebiotic fructooligosaccharides (FOS). Inhibition of pathogens was moderate by Sac. boulardii and L. rhamnosus GG, medium by L. reuteri DSM 17938 and the L. rhamnosus E/N, Oxy, Pen mixture and strong by the multi strain synbiotic. Head-to-head in-vitro pathogen growth inhibition experiments can be used to differentiate products from different categories containing probiotic microorganisms and can support the selection process of products for further clinical evaluation.

ACS Style

Jacek Piatek; Hanna Krauss; Arleta Ciechelska-Rybarczyk; Malgorzata Bernatek; Paulina Wojtyla-Buciora; Henning Sommermeyer. In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters. International Journal of Environmental Research and Public Health 2020, 17, 3332 .

AMA Style

Jacek Piatek, Hanna Krauss, Arleta Ciechelska-Rybarczyk, Malgorzata Bernatek, Paulina Wojtyla-Buciora, Henning Sommermeyer. In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters. International Journal of Environmental Research and Public Health. 2020; 17 (9):3332.

Chicago/Turabian Style

Jacek Piatek; Hanna Krauss; Arleta Ciechelska-Rybarczyk; Malgorzata Bernatek; Paulina Wojtyla-Buciora; Henning Sommermeyer. 2020. "In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters." International Journal of Environmental Research and Public Health 17, no. 9: 3332.

Preprint content
Published: 07 February 2019
Reads 0
Downloads 0

Supplementation with probiotics is considered as alternative treatment or adjuvant therapy for a number of bacterial infections for which the use of antibiotics is either not recommended or emerging antibiotic resistance is a major concern. Inhibition of the growth of pathogenic bacteria has been related to a number of different activities of probiotic bacteria or yeasts, some of which are very specific for particular strains of probiotics. As the different inhibition activities might act additively or even synergistically, probiotic multistrain products are discussed as potentially being more effective in pathogen inhibition than products containing one or a small number of probiotic strains. The present study investigated the in vitro inhibition of Escherichia (E.) coli, Shigella spp., Salmonella (S.) typhimurium and Clostridum (Cl.) difficile, all being human pathogens of significant worldwide healthcare concerns. The probiotic containing the yeast Sacharomyces (S.) boulardii inhibited all four pathogens. Similar inhibitions were observed with a bacterial probiotic containing three different strains (Pen, E/N and Oxy) of Lactobacillus (Lc.) rhamnosus. Compared to the inhibition found for these probiotics, the inhibitory effects of a complex multistrain synbiotic, containing nine different probiotic strains (6 Lactobacilli and 3 Bifidobacteria) and the prebiotic fructooligosaccharide (FOS), were significantly stronger. The stronger inhibition by the complex multistrain synbiotic was observed for all four tested pathogens. Our findings support a hypothesis that complex synbiotic products containing a larger number of different strains combined with a prebiotic component might be more attractive candidates for further clinical characterization than simpler probiotics containing one or only few probiotic strains.

ACS Style

Jacek Piatek; Henning Sommermeyer; Arleta Ciechelska-Rybarczyk; Malgorzata Bernatek. In-vitro pathogen inhibition: Comparing the inhibitory effects of a complex multistrain synbiotic with simple probiotics containing the yeast Saccharomyces boulardii or Lactobacillus rhamnosus bacteria. 2019, 543819 .

AMA Style

Jacek Piatek, Henning Sommermeyer, Arleta Ciechelska-Rybarczyk, Malgorzata Bernatek. In-vitro pathogen inhibition: Comparing the inhibitory effects of a complex multistrain synbiotic with simple probiotics containing the yeast Saccharomyces boulardii or Lactobacillus rhamnosus bacteria. . 2019; ():543819.

Chicago/Turabian Style

Jacek Piatek; Henning Sommermeyer; Arleta Ciechelska-Rybarczyk; Malgorzata Bernatek. 2019. "In-vitro pathogen inhibition: Comparing the inhibitory effects of a complex multistrain synbiotic with simple probiotics containing the yeast Saccharomyces boulardii or Lactobacillus rhamnosus bacteria." , no. : 543819.